Paulson & Co’s Labcorp LH Stock Holding History

Paulson & Co’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,470	Closed	-$2.92M	–	101
2015 Q4	$2.92M	Buy	+27,470	New	+$2.83M	0.02%	65

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paulson & Co's LH Position: Q1 2016 in Review

Paulson & Co sold out of Labcorp (LH) in Q1 2016, closing a stake of 27,470 shares — an estimated $2.92M sold.

Paulson & Co first reported a position in LH in Q4 2015 and held it in 1 quarter. The position peaked at $2.92M in Q4 2015. 631 funds tracked by Wall St. Rank hold LH as of Q1 2016.

Paulson & Co reported no remaining Labcorp position as of Q1 2016 after selling out during the quarter.
Paulson & Co sold 27,470 Labcorp shares in Q1 2016, an estimated $2.92M.
Paulson & Co first reported a position in Labcorp in Q4 2015 and held it in 1 quarter.
Paulson & Co's Labcorp position peaked at $2.92M in Q4 2015.
631 funds tracked by Wall St. Rank held Labcorp as of Q1 2016.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.